ScholarWorks@Hanyang University

Browsing by Sieper, JoachimAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 7 of 7

Efficacy and Safety of Upadacitinib in a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2/3 Clinical Study of Patients with Active Ankylosing SpondylitisGo to Link

van der Heijde, Desiree; Song, In-Ho; Pangan, Aileen; Deodhar, Atul; Van den Bosch, Filip; Maksymowych, Walter P.; Kim, Tae-Hwan; Kishimoto, Mitsumasa; Everding, Andrea; Sui, Yunxia, et al.

ConferenceIssue Date2019Citation2019 ACR/ARP Annual MeetingPublisherWILEYPlaceUS
SCIESCOPUS
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trialGo to Linkopen access

van der Heijde, Desiree; Song, In-Ho; Pangan, Aileen L.; Deodhar, Atul; van den Bosch, Filip; Maksymowych, Walter P.; Kim, Tae-Hwan; Kishimoto, Mitsumasa; Everding, Andrea; Sui, Yunxia, et al.

ArticleIssue Date2019CitationLANCET, v.394, no.10214, pp.2108 - 2117PublisherELSEVIER SCIENCE INC
SCIESCOPUS
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trialGo to Link

Deodhar, Atul; van der Heijde, Desiree; Gensler, Lianne S.; Kim, Tae-Hwan; Maksymowych, Walter P.; Ostergaard, Mikkel; Poddubnyy, Denis; Marzo-Ortega, Helena; Bessette, Louis; Tomita, Tetsuya, et al.

ArticleIssue Date2020CitationLANCET, v.395, no.10217, pp.53 - 64PublisherELSEVIER SCIENCE INC
Ixekizumab in Non-Radiographic Axial Spondyloarthritis: Primary Results from a Phase 3 TrialGo to Link

Deodhar, Atul; van der Heijde, Desiree; Gensler, Lianne; Kim, Tae-Hwan; Maksymowych, Walter P.; Ostergaard, Mikkel; Poddubnyy, Denis; Marzo-Ortega, Helena; Bessette, Louis; Tomita, Tetsuya, et al.

ConferenceIssue Date2019Citation2019 ACR/ARP Annual MeetingPublisherWILEYPlaceUS
SCISCIESCOPUS
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trialGo to Link

van der Heijde, Desiree; Wei, James Cheng-Chung; Dougados, Maxime; Mease, Philip; Deodhar, Atul; Maksymowych, Walter P.; Van den Bosch, Filip; Sieper, Joachim; Tomita, Tetsuya; Landewe, Robert, et al.

ArticleIssue Date2018CitationThe Lancet, v.392, no.10163, pp 2441 - 2451PublisherElsevier Science Inc.
SCISCIESCOPUSKCI
Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 studyGo to Link

Baeten, Dominique; Ostergaard, Mikkel; Wei, James Cheng-Chung; Sieper, Joachim; Jarvinen, Pentti; Tam, Lai-Shan; Salvarani, Carlo; Kim, Tae-Hwan; Solinger, Alan; Datsenko, Yakov, et al.

ArticleIssue Date2018CitationAnnals of the Rheumatic Diseases, v.77, no.9, pp 1295 - 1302PublisherBMJ Publishing Group
SCIESCOPUS
Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One-Year Results of a Double-Blind, Placebo-Controlled Study and Open-Label ExtensionGo to Linkopen access

Deodhar, Atul; van der Heijde, Desiree; Sieper, Joachim; Van den Bosch, Filip; Maksymowych, Walter P.; Kim, Tae-Hwan; Kishimoto, Mitsumasa; Ostor, Andrew; Combe, Bernard; Sui, Yunxia, et al.

ArticleIssue Date2021CitationARTHRITIS & RHEUMATOLOGY, v.74, no.1, pp.70 - 80PublisherWILEY
1
CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

COPYRIGHT © 2024 HANYANG UNIVERSITY.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어